Gilead Sciences/ US3755581036 /
| 2024-12-20 9:59:59 PM | Chg. +1.52 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 92.58USD | +1.66% | 276,076 Turnover: 25.55 mill. |
-Bid Size: - | -Ask Size: - | 115.37 bill.USD | 3.24% | 20.39 |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 4,006 | 4,502 | 4,967 | 5,121 | 5,475 | ||||||
| Intangible Assets | 15,738 | 13,786 | 33,126 | 33,455 | 28,894 | ||||||
| Long-Term Investments | 1,423 | 1,488 | 502 | 1,309 | 1,245 | ||||||
| Fixed Assets | 27,839 | 31,331 | 52,411 | 53,180 | 48,728 | ||||||
| Inventories | 814 | 922 | 1,683 | 1,618 | 1,507 | ||||||
| Accounts Receivable | 3,327 | 3,582 | 4,892 | 4,493 | 4,777 | ||||||
| Cash and Cash Equivalents | 17,940 | 11,631 | 5,997 | 5,338 | 5,412 | ||||||
| Current Assets | 35,836 | 30,296 | 15,996 | 14,772 | 14,443 | ||||||
| Total Assets | 63,675 | 61,627 | 68,407 | 67,952 | 63,171 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 790 | 713 | 844 | 705 | 905 | ||||||
| Long-term debt | 24,574 | 22,094 | 28,645 | 25,179 | 22,957 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 42,141 | 38,977 | 50,186 | 46,888 | 41,962 | ||||||
| Share Capital | 1 | 1 | 1 | 1 | 1 | ||||||
| Total Equity | 21,534 | 22,650 | 18,221 | 21,064 | 21,209 | ||||||
| Minority Interests | 147 | 125 | 19 | -5 | -31 | ||||||
| Total liabilities equity | 63,675 | 61,627 | 68,407 | 67,952 | 63,171 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 22,127 | 22,449 | 24,689 | 27,305 | 27,281 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 8,200 | 4,287 | 4,071 | 9,918 | 7,330 | ||||||
| Interest Income | -1,077 | -995 | -984 | -1,001 | -935 | ||||||
| Income Before Taxes | 7,799 | 5,160 | 1,669 | 8,278 | 5,814 | ||||||
| Income Taxes | 2,339 | -204 | 1,580 | -2,077 | -1,248 | ||||||
| Minority Interests Profit | 5 | -22 | -34 | 24 | 26 | ||||||
| Net Income | 5,455 | 5,386 | 123 | 6,225 | 4,592 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 8,400 | 9,144 | 8,168 | 11,384 | 9,072 | ||||||
| Cash Flow from Investing Activities | 14,355 | -7,817 | -14,615 | -3,131 | -2,466 | ||||||
| Cash Flow from Financing | -12,318 | -7,634 | 770 | -8,877 | -6,469 | ||||||
| Decrease / Increase in Cash | 10,352 | -6,309 | -5,634 | -659 | 74 | ||||||
| Employees | 11,000 | 11,800 | 13,600 | 14,000 | - | ||||||
